Genetically defined systemic autoinflammatory diseases in pediatric patients with Behçet’s disease
Authors:
Open Access
- 18 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1897406
Abstract
Objectives: The aim of this study was to characterize the genetic basis of Behçet’s disease (BD) and mimics in a pediatric cohort. Methods: We retrospectively studied 34 patients of pediatric BD and mimics who underwent whole-exome sequencing (WES) in our center from 2020 to 2025. Clinical characteristics and laboratory parameters of the patients with or without genetically defined systemic autoinflammatory diseases (SAIDs) were compared. Results: WES identified 10 probands with genetically defined SAID (the SAID+ group). Nine probands possessed pathogenic or likely pathogenic germline variants in RELA , TNFAIP3 (encoding A20), or GATA2 . One proband was found to have trisomy 8. Five of the SAID+ probands exhibited parentally inherited variants, while the remaining four probands possessed de novo variants. Compared to pediatric BD patients without genetically determined SAID (the ped-BD group, n = 24), the SAID+ group exhibited earlier disease onset and greater prevalence of recurrent fever episodes, intestinal involvement, and hematologic abnormalities. Laboratory studies revealed higher levels of inflammatory markers and serum cytokines including IL-1β, IL-2, IL-10, and TNFα in the SAID+ group. Corticosteroid treatment was commonly utilized in all patients, while the use of biologic DMARDs was more common in the SAID+ group. Conclusion: Pediatric patients with autoinflammatory diseases mimicking BD have heightened systemic inflammation and more severe organ involvement that necessitate intensified immunosuppressive regimens. Genetic evaluation should be considered for BD cases with early disease onset, recurrent fever, enteritis, intestinal ulcers, or hematologic abnormalities.Keywords
This publication has 21 references indexed in Scilit:
- The Complexity of Being A20: From Biological Functions to Genetic AssociationsJournal of Clinical Immunology, 2024
- Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutationInternational Journal of Hematology, 2023
- Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in childrenJournal of Allergy and Clinical Immunology, 2023
- A Novel RELA Truncating Mutation in a Familial Behçet’s Disease–like Mucocutaneous Ulcerative ConditionArthritis & Rheumatology, 2020
- Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiencyJournal of Allergy and Clinical Immunology, 2020
- Juvenile-onset Behçet's syndrome and mimicsClinical Immunology, 2020
- Systemic autoinflammatory diseasesJournal of Autoimmunity, 2020
- Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutationJournal of Allergy and Clinical Immunology, 2019
- From Wet‐Lab to Variations: Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome SequencingHuman Mutation, 2016
- Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory diseaseNature Genetics, 2015